Soleno Therapeutics, Inc. (SLNO) Misses Q4 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q4 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
• Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction